mnkd-10q_20220630.htm
false Q2 0000899460 --12-31 P2Y11M1D P1Y9M21D P4Y true http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent 2018-02-28 P2Y 0.11 0.14 0.22 0.20 253644000 249295000 252775000 247970000 0.11 0.14 0.22 0.20 P39Y P3Y P1Y P3Y P3Y P40Y P40Y P15Y P10Y P15Y 18400000 400000 0.0625 0.01 253644000 249295000 252775000 247970000 0.11 0.14 0.22 0.20 P19Y3M18D P19Y9M18D P5Y1M6D P2Y7M6D 0000899460 2022-01-01 2022-06-30 xbrli:shares 0000899460 2022-07-29 iso4217:USD 0000899460 2022-06-30 0000899460 2021-12-31 iso4217:USD xbrli:shares 0000899460 us-gaap:ProductMember 2022-04-01 2022-06-30 0000899460 us-gaap:ProductMember 2021-04-01 2021-06-30 0000899460 us-gaap:ProductMember 2022-01-01 2022-06-30 0000899460 us-gaap:ProductMember 2021-01-01 2021-06-30 0000899460 us-gaap:LicenseAndServiceMember 2022-04-01 2022-06-30 0000899460 us-gaap:LicenseAndServiceMember 2021-04-01 2021-06-30 0000899460 us-gaap:LicenseAndServiceMember 2022-01-01 2022-06-30 0000899460 us-gaap:LicenseAndServiceMember 2021-01-01 2021-06-30 0000899460 us-gaap:RoyaltyMember 2022-04-01 2022-06-30 0000899460 us-gaap:RoyaltyMember 2022-01-01 2022-06-30 0000899460 2022-04-01 2022-06-30 0000899460 2021-04-01 2021-06-30 0000899460 2021-01-01 2021-06-30 0000899460 us-gaap:CommonStockMember 2020-12-31 0000899460 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000899460 us-gaap:RetainedEarningsMember 2020-12-31 0000899460 2020-12-31 0000899460 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000899460 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0000899460 2021-01-01 2021-03-31 0000899460 us-gaap:CommonStockMember mnkd:ConvertibleNotesMember mnkd:TheMannGroupLLCMember 2021-01-01 2021-03-31 0000899460 us-gaap:AdditionalPaidInCapitalMember mnkd:ConvertibleNotesMember mnkd:TheMannGroupLLCMember 2021-01-01 2021-03-31 0000899460 mnkd:ConvertibleNotesMember mnkd:TheMannGroupLLCMember 2021-01-01 2021-03-31 0000899460 us-gaap:CommonStockMember mnkd:ConvertibleNoteInterestMember mnkd:TheMannGroupLLCMember 2021-01-01 2021-03-31 0000899460 us-gaap:AdditionalPaidInCapitalMember mnkd:ConvertibleNoteInterestMember mnkd:TheMannGroupLLCMember 2021-01-01 2021-03-31 0000899460 mnkd:ConvertibleNoteInterestMember mnkd:TheMannGroupLLCMember 2021-01-01 2021-03-31 0000899460 us-gaap:CommonStockMember mnkd:TwoThousandTwentyFourConvertibleNotesMember 2021-01-01 2021-03-31 0000899460 us-gaap:AdditionalPaidInCapitalMember mnkd:TwoThousandTwentyFourConvertibleNotesMember 2021-01-01 2021-03-31 0000899460 mnkd:TwoThousandTwentyFourConvertibleNotesMember 2021-01-01 2021-03-31 0000899460 us-gaap:CommonStockMember mnkd:TwoThousandTwentyFourConvertibleNoteInterestMember 2021-01-01 2021-03-31 0000899460 us-gaap:AdditionalPaidInCapitalMember mnkd:TwoThousandTwentyFourConvertibleNoteInterestMember 2021-01-01 2021-03-31 0000899460 mnkd:TwoThousandTwentyFourConvertibleNoteInterestMember 2021-01-01 2021-03-31 0000899460 us-gaap:CommonStockMember mnkd:AtTheMarketOfferingMember 2021-01-01 2021-03-31 0000899460 us-gaap:AdditionalPaidInCapitalMember mnkd:AtTheMarketOfferingMember 2021-01-01 2021-03-31 0000899460 mnkd:AtTheMarketOfferingMember 2021-01-01 2021-03-31 0000899460 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000899460 us-gaap:CommonStockMember 2021-03-31 0000899460 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000899460 us-gaap:RetainedEarningsMember 2021-03-31 0000899460 2021-03-31 0000899460 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0000899460 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0000899460 us-gaap:AdditionalPaidInCapitalMember mnkd:TheMannGroupLLCMember 2021-04-01 2021-06-30 0000899460 mnkd:TheMannGroupLLCMember 2021-04-01 2021-06-30 0000899460 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0000899460 us-gaap:CommonStockMember 2021-06-30 0000899460 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000899460 us-gaap:RetainedEarningsMember 2021-06-30 0000899460 2021-06-30 0000899460 us-gaap:CommonStockMember 2021-12-31 0000899460 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000899460 us-gaap:RetainedEarningsMember 2021-12-31 0000899460 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000899460 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000899460 2022-01-01 2022-03-31 0000899460 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000899460 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000899460 us-gaap:CommonStockMember 2022-03-31 0000899460 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000899460 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000899460 us-gaap:RetainedEarningsMember 2022-03-31 0000899460 2022-03-31 0000899460 us-gaap:CommonStockMember mnkd:ConvertibleNotesMember 2022-04-01 2022-06-30 0000899460 us-gaap:AdditionalPaidInCapitalMember mnkd:ConvertibleNotesMember 2022-04-01 2022-06-30 0000899460 mnkd:ConvertibleNotesMember 2022-04-01 2022-06-30 0000899460 us-gaap:CommonStockMember mnkd:ConvertibleNoteInterestMember 2022-04-01 2022-06-30 0000899460 us-gaap:AdditionalPaidInCapitalMember mnkd:ConvertibleNoteInterestMember 2022-04-01 2022-06-30 0000899460 mnkd:ConvertibleNoteInterestMember 2022-04-01 2022-06-30 0000899460 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0000899460 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0000899460 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0000899460 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0000899460 us-gaap:CommonStockMember 2022-06-30 0000899460 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000899460 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0000899460 us-gaap:RetainedEarningsMember 2022-06-30 0000899460 mnkd:AtTheMarketIssuanceMember 2021-01-01 2021-06-30 0000899460 mnkd:TheMannGroupLLCMember 2021-01-01 2021-06-30 0000899460 mnkd:VGoMember 2022-01-01 2022-06-30 0000899460 mnkd:MidCapCreditFacilityMember 2019-08-31 0000899460 mnkd:MidCapCreditFacilityMember 2022-06-30 0000899460 mnkd:MidCapCreditFacilityMember mnkd:TrancheThreeMember 2022-06-30 0000899460 2021-03-01 2021-03-31 xbrli:pure mnkd:Segment 0000899460 us-gaap:ProductMember srt:MaximumMember 2022-01-01 2022-06-30 0000899460 us-gaap:ProductMember srt:MinimumMember 2022-01-01 2022-06-30 0000899460 us-gaap:LicenseAndServiceMember 2022-01-01 2022-06-30 0000899460 mnkd:ProductSalesMember 2022-04-01 2022-06-30 0000899460 mnkd:ProductSalesMember 2021-04-01 2021-06-30 0000899460 mnkd:ProductSalesMember 2022-01-01 2022-06-30 0000899460 mnkd:ProductSalesMember 2021-01-01 2021-06-30 0000899460 us-gaap:ServiceMember 2022-04-01 2022-06-30 0000899460 us-gaap:ServiceMember 2021-04-01 2021-06-30 0000899460 us-gaap:ServiceMember 2022-01-01 2022-06-30 0000899460 us-gaap:ServiceMember 2021-01-01 2021-06-30 0000899460 mnkd:ConvertiblePromissoryNoteMember mnkd:ThironaBioIncMember 2021-06-01 2021-06-30 0000899460 mnkd:ConvertiblePromissoryNoteMember mnkd:ThironaBioIncMember 2022-01-01 2022-01-31 0000899460 mnkd:ConvertiblePromissoryNoteMember mnkd:ThironaBioIncMember 2021-06-30 0000899460 mnkd:InsulinMember 2022-06-30 0000899460 mnkd:InsulinMember 2021-12-31 mnkd:Contract 0000899460 mnkd:InsulinMember 2022-01-01 2022-06-30 0000899460 mnkd:MilestoneRightsLiabilityMember mnkd:DeerfieldManagementCompanyLpMember srt:MaximumMember 2013-07-01 0000899460 mnkd:MilestoneRightsLiabilityMember mnkd:DeerfieldManagementCompanyLpMember 2013-07-01 0000899460 mnkd:MilestoneRightsLiabilityMember mnkd:DeerfieldManagementCompanyLpMember 2022-06-30 0000899460 mnkd:VGoMember 2022-05-31 2022-05-31 0000899460 mnkd:VGoMember srt:MaximumMember 2022-05-31 0000899460 mnkd:VGoMember srt:MinimumMember 2022-05-31 2022-05-31 0000899460 mnkd:VGoMember srt:MaximumMember 2022-05-31 2022-05-31 0000899460 mnkd:VGoMember 2022-05-31 0000899460 2022-05-31 0000899460 mnkd:VGoMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-05-31 0000899460 mnkd:VGoMember us-gaap:MeasurementInputExpectedDividendRateMember 2022-05-31 0000899460 mnkd:VGoMember us-gaap:MeasurementInputPriceVolatilityMember 2022-05-31 mnkd:Year 0000899460 mnkd:VGoMember us-gaap:MeasurementInputExpectedTermMember 2022-05-31 0000899460 mnkd:VGoMember us-gaap:MeasurementInputEntityCreditRiskMember 2022-05-31 0000899460 mnkd:VGoMember 2022-06-30 0000899460 2022-05-31 2022-06-30 0000899460 mnkd:ConvertiblePromissoryNoteMember mnkd:ThironaBioIncMember 2022-06-30 0000899460 mnkd:ConvertiblePromissoryNoteMember mnkd:ThironaBioIncMember 2021-12-31 0000899460 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member mnkd:AmortizedCostMember 2022-06-30 0000899460 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member mnkd:GrossUnrealizedHoldingLossesMember 2022-06-30 0000899460 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member mnkd:EstimatedFairValueMember 2022-06-30 0000899460 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member mnkd:AmortizedCostMember 2022-06-30 0000899460 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member mnkd:EstimatedFairValueMember 2022-06-30 0000899460 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel2Member mnkd:AmortizedCostMember 2022-06-30 0000899460 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel2Member mnkd:GrossUnrealizedHoldingLossesMember 2022-06-30 0000899460 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel2Member mnkd:EstimatedFairValueMember 2022-06-30 0000899460 mnkd:AmortizedCostMember 2022-06-30 0000899460 mnkd:GrossUnrealizedHoldingLossesMember 2022-06-30 0000899460 mnkd:EstimatedFairValueMember 2022-06-30 0000899460 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member mnkd:AmortizedCostMember 2021-12-31 0000899460 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member mnkd:GrossUnrealizedHoldingLossesMember 2021-12-31 0000899460 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member mnkd:EstimatedFairValueMember 2021-12-31 0000899460 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member mnkd:AmortizedCostMember 2021-12-31 0000899460 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member mnkd:EstimatedFairValueMember 2021-12-31 0000899460 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel2Member mnkd:AmortizedCostMember 2021-12-31 0000899460 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel2Member mnkd:GrossUnrealizedHoldingLossesMember 2021-12-31 0000899460 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel2Member mnkd:EstimatedFairValueMember 2021-12-31 0000899460 mnkd:AmortizedCostMember 2021-12-31 0000899460 mnkd:GrossUnrealizedHoldingLossesMember 2021-12-31 0000899460 mnkd:EstimatedFairValueMember 2021-12-31 0000899460 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2022-06-30 0000899460 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2021-12-31 0000899460 us-gaap:ProductMember 2022-06-30 0000899460 us-gaap:ProductMember 2021-12-31 0000899460 us-gaap:LicenseAndServiceMember 2022-06-30 0000899460 us-gaap:LicenseAndServiceMember 2021-12-31 mnkd:Distributor 0000899460 mnkd:UnitedTherapeuticsCorporationMember 2022-01-01 2022-06-30 0000899460 mnkd:PreLaunchInventoryMember 2022-06-30 0000899460 mnkd:PreLaunchInventoryMember 2021-12-31 0000899460 us-gaap:LandMember 2022-06-30 0000899460 us-gaap:LandMember 2021-12-31 0000899460 us-gaap:BuildingMember 2022-06-30 0000899460 us-gaap:BuildingMember 2021-12-31 0000899460 us-gaap:BuildingImprovementsMember 2022-06-30 0000899460 us-gaap:BuildingImprovementsMember 2021-12-31 0000899460 us-gaap:MachineryAndEquipmentMember 2022-06-30 0000899460 us-gaap:MachineryAndEquipmentMember 2021-12-31 0000899460 mnkd:FurnitureFixturesAndOfficeEquipmentMember 2022-06-30 0000899460 mnkd:FurnitureFixturesAndOfficeEquipmentMember 2021-12-31 0000899460 mnkd:ComputerEquipmentAndSoftwareMember 2022-06-30 0000899460 mnkd:ComputerEquipmentAndSoftwareMember 2021-12-31 0000899460 us-gaap:ConstructionInProgressMember 2022-06-30 0000899460 us-gaap:ConstructionInProgressMember 2021-12-31 0000899460 us-gaap:BuildingMember srt:MinimumMember 2022-01-01 2022-06-30 0000899460 us-gaap:BuildingMember srt:MaximumMember 2022-01-01 2022-06-30 0000899460 us-gaap:BuildingImprovementsMember srt:MinimumMember 2022-01-01 2022-06-30 0000899460 us-gaap:BuildingImprovementsMember srt:MaximumMember 2022-01-01 2022-06-30 0000899460 us-gaap:MachineryAndEquipmentMember srt:MinimumMember 2022-01-01 2022-06-30 0000899460 us-gaap:MachineryAndEquipmentMember srt:MaximumMember 2022-01-01 2022-06-30 0000899460 mnkd:FurnitureFixturesAndOfficeEquipmentMember srt:MinimumMember 2022-01-01 2022-06-30 0000899460 mnkd:FurnitureFixturesAndOfficeEquipmentMember srt:MaximumMember 2022-01-01 2022-06-30 0000899460 mnkd:ComputerEquipmentAndSoftwareMember 2022-01-01 2022-06-30 0000899460 mnkd:UTEquipmentMember 2021-12-31 0000899460 mnkd:UTEquipmentMember 2022-06-30 0000899460 mnkd:UTEquipmentMember 2021-01-01 2021-12-31 0000899460 mnkd:UTEquipmentMember 2022-01-01 2022-06-30 0000899460 mnkd:CasperLLCMember 2021-11-08 2021-11-08 0000899460 us-gaap:DevelopedTechnologyRightsMember 2022-01-01 2022-06-30 0000899460 us-gaap:DevelopedTechnologyRightsMember 2022-06-30 0000899460 mnkd:MidCapCreditFacilityMember 2021-12-31 0000899460 us-gaap:SeniorNotesMember 2022-06-30 0000899460 mnkd:TheMannGroupLLCMember mnkd:ConvertiblePromissoryNoteMember 2022-06-30 0000899460 us-gaap:SeniorNotesMember 2021-12-31 0000899460 mnkd:TheMannGroupLLCMember mnkd:ConvertiblePromissoryNoteMember 2021-12-31 0000899460 us-gaap:LondonInterbankOfferedRateLIBORMember mnkd:MidCapCreditFacilityMember 2022-06-30 0000899460 us-gaap:LondonInterbankOfferedRateLIBORMember mnkd:MidCapCreditFacilityMember 2022-01-01 2022-06-30 0000899460 us-gaap:SeniorNotesMember 2022-01-01 2022-06-30 0000899460 mnkd:MidCapCreditFacilityMember 2022-01-01 2022-06-30 0000899460 mnkd:TheMannGroupLLCMember mnkd:ConvertiblePromissoryNoteMember 2022-01-01 2022-06-30 0000899460 mnkd:MidCapCreditFacilityMember 2021-04-01 2021-04-30 0000899460 mnkd:MidCapCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember mnkd:PriorToMidcapCreditFacilityAmendmentMember 2021-04-30 0000899460 mnkd:MidCapCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember mnkd:PriorToMidcapCreditFacilityAmendmentMember 2021-04-01 2021-04-30 0000899460 mnkd:MidCapCreditFacilityMember mnkd:PriorToMidcapCreditFacilityAmendmentMember 2021-04-01 2021-04-30 0000899460 mnkd:NonConvertiblePromissoryNoteMember mnkd:TheMannGroupLLCMember mnkd:PriorToFirstAmendmentMember 2021-04-30 0000899460 mnkd:NonConvertiblePromissoryNoteMember mnkd:TheMannGroupLLCMember mnkd:PriorToFirstAmendmentMember 2021-04-01 2021-04-30 0000899460 us-gaap:SeniorNotesMember us-gaap:PrivatePlacementMember 2021-03-04 0000899460 us-gaap:SeniorNotesMember us-gaap:PrivatePlacementMember 2021-03-15 utr:D 0000899460 us-gaap:SeniorNotesMember 2021-03-04 2021-03-04 0000899460 us-gaap:SeniorNotesMember 2021-03-04 0000899460 us-gaap:SeniorNotesMember srt:MinimumMember 2021-03-04 0000899460 mnkd:TrancheOneMember mnkd:MidCapCreditFacilityMember 2019-08-01 2019-08-31 0000899460 mnkd:TrancheTwoMember mnkd:MidCapCreditFacilityMember 2020-01-01 2020-12-31 0000899460 mnkd:MidCapCreditFacilityMember mnkd:TrancheThreeMember 2021-03-31 0000899460 mnkd:MidCapCreditFacilityMember mnkd:TrancheThreeMember 2021-04-30 0000899460 mnkd:MidCapCreditFacilityMember mnkd:TrancheThreeMember 2021-04-01 2021-04-30 0000899460 mnkd:MidCapCreditFacilityMember mnkd:TrancheThreeMember 2022-01-01 2022-06-30 0000899460 mnkd:TrancheOneMember mnkd:MidCapCreditFacilityMember 2019-08-31 0000899460 mnkd:TrancheTwoMember mnkd:MidCapCreditFacilityMember 2020-12-31 0000899460 us-gaap:LondonInterbankOfferedRateLIBORMember mnkd:TrancheOneMember mnkd:MidCapCreditFacilityMember 2019-08-01 2019-08-31 0000899460 us-gaap:LondonInterbankOfferedRateLIBORMember mnkd:TrancheTwoMember mnkd:MidCapCreditFacilityMember 2020-12-01 2020-12-31 mnkd:Installment 0000899460 mnkd:TrancheTwoMember mnkd:MidCapCreditFacilityMember 2020-12-01 2020-12-31 0000899460 us-gaap:DebtInstrumentRedemptionPeriodTwoMember mnkd:MidCapCreditFacilityMember 2022-01-01 2022-06-30 0000899460 us-gaap:DebtInstrumentRedemptionPeriodOneMember mnkd:MidCapCreditFacilityMember 2022-01-01 2022-06-30 0000899460 us-gaap:DebtInstrumentRedemptionPeriodThreeMember mnkd:MidCapCreditFacilityMember 2022-01-01 2022-06-30 0000899460 mnkd:MidCapCreditFacilityMember 2019-08-01 2019-08-31 0000899460 mnkd:ConvertiblePromissoryNoteMember mnkd:LoanArrangementMember mnkd:PrivatelyNegotiatedExchangeAgreementMember mnkd:TheMannGroupLLCMember 2019-08-31 0000899460 mnkd:LoanArrangementMember mnkd:PrivatelyNegotiatedExchangeAgreementMember mnkd:TheMannGroupLLCMember 2019-08-31 0000899460 mnkd:NonConvertibleNoteMember mnkd:LoanArrangementMember mnkd:PrivatelyNegotiatedExchangeAgreementMember mnkd:TheMannGroupLLCMember 2019-08-31 0000899460 mnkd:TheMannGroupLLCMember mnkd:NewLoanArrangementMember mnkd:PromissoryNotesMember 2019-08-31 0000899460 mnkd:TheMannGroupLLCMember mnkd:NewLoanArrangementMember mnkd:PromissoryNotesMember 2021-04-30 0000899460 mnkd:TheMannGroupLLCMember mnkd:NewLoanArrangementMember mnkd:PromissoryNotesMember 2019-08-01 2019-08-31 0000899460 2019-08-01 2019-08-31 0000899460 2021-04-01 2021-04-30 0000899460 mnkd:TheMannGroupLLCMember mnkd:ConvertiblePromissoryNoteMember 2021-04-01 2021-04-30 0000899460 mnkd:PromissoryNotesMember mnkd:TheMannGroupLLCMember 2021-12-31 0000899460 mnkd:PromissoryNotesMember mnkd:TheMannGroupLLCMember 2021-01-01 2021-12-31 0000899460 mnkd:ConvertiblePromissoryNoteMember mnkd:NewLoanArrangementMember mnkd:TheMannGroupLLCMember 2019-08-01 2019-08-31 0000899460 mnkd:ConvertiblePromissoryNoteMember mnkd:NewLoanArrangementMember mnkd:TheMannGroupLLCMember 2019-08-31 0000899460 mnkd:ConvertiblePromissoryNoteMember mnkd:TheMannGroupLLCMember 2022-04-01 2022-06-30 0000899460 2021-01-01 2021-12-31 0000899460 mnkd:CommercialSupplyAgreementMember mnkd:UnitedTherapeuticsCorporationMember us-gaap:LicenseAndServiceMember 2022-04-01 2022-06-30 0000899460 mnkd:CommercialSupplyAgreementMember mnkd:UnitedTherapeuticsCorporationMember us-gaap:LicenseAndServiceMember 2022-01-01 2022-06-30 0000899460 mnkd:LicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember us-gaap:LicenseAndServiceMember 2022-04-01 2022-06-30 0000899460 mnkd:LicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember us-gaap:LicenseAndServiceMember 2021-04-01 2021-06-30 0000899460 mnkd:LicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember us-gaap:LicenseAndServiceMember 2022-01-01 2022-06-30 0000899460 mnkd:LicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember us-gaap:LicenseAndServiceMember 2021-01-01 2021-06-30 0000899460 mnkd:CoPromotionAgreementMember us-gaap:LicenseAndServiceMember mnkd:VerticePharmaLLCMember 2022-04-01 2022-06-30 0000899460 mnkd:CoPromotionAgreementMember us-gaap:LicenseAndServiceMember mnkd:VerticePharmaLLCMember 2021-04-01 2021-06-30 0000899460 mnkd:CoPromotionAgreementMember us-gaap:LicenseAndServiceMember mnkd:VerticePharmaLLCMember 2022-01-01 2022-06-30 0000899460 mnkd:CoPromotionAgreementMember us-gaap:LicenseAndServiceMember mnkd:VerticePharmaLLCMember 2021-01-01 2021-06-30 0000899460 mnkd:LicenseAndDistributionAgreementMember us-gaap:LicenseAndServiceMember mnkd:CiplaLtdMember 2022-04-01 2022-06-30 0000899460 mnkd:LicenseAndDistributionAgreementMember us-gaap:LicenseAndServiceMember mnkd:CiplaLtdMember 2021-04-01 2021-06-30 0000899460 mnkd:LicenseAndDistributionAgreementMember us-gaap:LicenseAndServiceMember mnkd:CiplaLtdMember 2022-01-01 2022-06-30 0000899460 mnkd:LicenseAndDistributionAgreementMember us-gaap:LicenseAndServiceMember mnkd:CiplaLtdMember 2021-01-01 2021-06-30 0000899460 mnkd:OtherAgreementMember us-gaap:LicenseAndServiceMember 2022-04-01 2022-06-30 0000899460 mnkd:OtherAgreementMember us-gaap:LicenseAndServiceMember 2021-04-01 2021-06-30 0000899460 mnkd:OtherAgreementMember us-gaap:LicenseAndServiceMember 2022-01-01 2022-06-30 0000899460 mnkd:OtherAgreementMember us-gaap:LicenseAndServiceMember 2021-01-01 2021-06-30 0000899460 mnkd:CollaborationAndLicenseAgreementMember us-gaap:LicenseAndServiceMember mnkd:ReceptorLifeScienceIncMember 2021-04-01 2021-06-30 0000899460 mnkd:CollaborationAndLicenseAgreementMember us-gaap:LicenseAndServiceMember mnkd:ReceptorLifeScienceIncMember 2021-01-01 2021-06-30 0000899460 mnkd:UnitedTherapeuticsCorporationMember mnkd:CommercialSupplyAgreementMember 2022-04-01 2022-06-30 0000899460 mnkd:UnitedTherapeuticsCorporationMember mnkd:CommercialSupplyAgreementMember 2022-01-01 2022-06-30 0000899460 mnkd:UnitedTherapeuticsCorporationMember mnkd:LicenseAgreementMember 2022-04-01 2022-06-30 0000899460 mnkd:UnitedTherapeuticsCorporationMember mnkd:LicenseAgreementMember 2021-04-01 2021-06-30 0000899460 mnkd:UnitedTherapeuticsCorporationMember mnkd:LicenseAgreementMember 2022-01-01 2022-06-30 0000899460 mnkd:UnitedTherapeuticsCorporationMember mnkd:LicenseAgreementMember 2021-01-01 2021-06-30 0000899460 mnkd:UnitedTherapeuticsCorporationMember mnkd:RoyaltiesArrangementMember 2022-04-01 2022-06-30 0000899460 mnkd:UnitedTherapeuticsCorporationMember mnkd:RoyaltiesArrangementMember 2022-01-01 2022-06-30 0000899460 mnkd:UnitedTherapeuticsCorporationMember 2022-04-01 2022-06-30 0000899460 mnkd:UnitedTherapeuticsCorporationMember 2021-04-01 2021-06-30 0000899460 mnkd:UnitedTherapeuticsCorporationMember 2021-01-01 2021-06-30 0000899460 mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember 2018-10-31 0000899460 mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember 2019-04-01 2020-11-30 0000899460 srt:MaximumMember mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember 2022-06-30 0000899460 mnkd:CommercialSupplyAgreementMember 2022-01-01 2022-06-30 0000899460 mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember 2021-10-31 0000899460 mnkd:NextGenResearchAndDevelopmentServicesMember us-gaap:TransferredOverTimeMember mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember 2021-10-31 0000899460 mnkd:ManufacturingServicesMember us-gaap:TransferredAtPointInTimeMember mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember 2021-10-31 0000899460 mnkd:ResearchAndDevelopmentServicesAndLicenseMember us-gaap:TransferredOverTimeMember mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember 2021-10-31 2021-10-31 0000899460 mnkd:NextGenResearchAndDevelopmentServicesMember us-gaap:TransferredOverTimeMember mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember 2021-10-31 2021-10-31 0000899460 mnkd:ManufacturingServicesMember us-gaap:TransferredAtPointInTimeMember mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember 2021-10-31 2021-10-31 0000899460 mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember mnkd:ManufacturingServicesMember mnkd:TransactionPriceForTheContractualObligationsMember 2021-10-31 0000899460 mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember mnkd:NextGenResearchAndDevelopmentServicesMember mnkd:TransactionPriceForThePerformanceObligationsMember 2021-10-31 0000899460 mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember mnkd:ManufacturingServicesMember 2021-10-31 2021-10-31 0000899460 mnkd:UnitedTherapeuticsCorporationMember mnkd:CommercializationAndContinuousImprovementActivitiesMember 2022-04-01 2022-04-30 0000899460 mnkd:UnitedTherapeuticsCorporationMember mnkd:ManufacturingServicesMember 2022-04-01 2022-04-30 0000899460 mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember 2022-04-30 0000899460 mnkd:NextGenResearchAndDevelopmentServicesMember us-gaap:TransferredOverTimeMember mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember 2022-04-30 0000899460 mnkd:ManufacturingServicesAndProductSalesMember us-gaap:TransferredAtPointInTimeMember mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember 2022-04-30 0000899460 mnkd:ResearchAndDevelopmentServicesAndLicenseMember us-gaap:TransferredOverTimeMember mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember 2022-01-01 2022-06-30 0000899460 mnkd:NextGenResearchAndDevelopmentServicesMember us-gaap:TransferredOverTimeMember mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember 2022-01-01 2022-06-30 0000899460 mnkd:ManufacturingServicesAndProductSalesMember us-gaap:TransferredAtPointInTimeMember mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember 2022-04-01 2022-04-30 0000899460 mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember mnkd:ManufacturingServicesMember mnkd:TransactionPriceForTheContractualObligationsMember 2022-04-30 0000899460 mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember mnkd:NextGenResearchAndDevelopmentServicesMember mnkd:TransactionPriceForThePerformanceObligationsMember 2022-04-30 0000899460 mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember mnkd:ManufacturingServicesMember 2022-04-01 2022-04-30 0000899460 mnkd:CollaborationAndLicenseAgreementMember mnkd:UnitedTherapeuticsCorporationMember 2022-06-30 0000899460 mnkd:CoPromotionAgreementMember us-gaap:LicenseAndServiceMember 2021-12-31 0000899460 mnkd:CoPromotionAgreementMember us-gaap:LicenseAndServiceMember mnkd:VerticePharmaLLCMember 2022-06-01 2022-06-30 0000899460 mnkd:SupplyAndDistributionAgreementMember mnkd:BiommSAMember us-gaap:ProductMember 2022-01-01 2022-06-30 0000899460 mnkd:SupplyAndDistributionAgreementMember mnkd:BiommSAMember us-gaap:ProductMember 2021-01-01 2021-12-31 0000899460 mnkd:LicenseAndDistributionAgreementMember mnkd:CiplaLtdMember 2018-05-01 2018-05-31 0000899460 2018-06-01 mnkd:LicenseAndDistributionAgreementMember mnkd:CiplaLtdMember 2018-05-31 0000899460 mnkd:LicenseAndDistributionAgreementMember mnkd:CiplaLtdMember 2022-06-30 0000899460 us-gaap:MoneyMarketFundsMember 2022-06-30 0000899460 us-gaap:MoneyMarketFundsMember 2021-12-31 0000899460 us-gaap:SeniorNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-06-30 0000899460 us-gaap:FairValueInputsLevel3Member us-gaap:SeniorNotesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-06-30 0000899460 us-gaap:SeniorNotesMember 2022-06-30 0000899460 mnkd:MidCapCreditFacilityMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-06-30 0000899460 us-gaap:FairValueInputsLevel3Member mnkd:MidCapCreditFacilityMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-06-30 0000899460 mnkd:MannGroupConvertibleNoteMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-06-30 0000899460 us-gaap:FairValueInputsLevel3Member mnkd:MannGroupConvertibleNoteMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-06-30 0000899460 mnkd:MannGroupConvertibleNoteMember 2022-06-30 0000899460 mnkd:MilestoneRightsLiabilityMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-06-30 0000899460 us-gaap:FairValueInputsLevel3Member mnkd:MilestoneRightsLiabilityMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-06-30 0000899460 mnkd:MilestoneRightsLiabilityMember 2022-06-30 0000899460 mnkd:MannGroupConvertibleNoteMember 2022-06-30 0000899460 us-gaap:SeniorNotesMember us-gaap:MeasurementInputPriceVolatilityMember 2022-06-30 0000899460 mnkd:MannGroupConvertibleNoteMember us-gaap:MeasurementInputPriceVolatilityMember 2022-06-30 0000899460 us-gaap:SeniorNotesMember 2022-01-01 2022-06-30 0000899460 mnkd:MannGroupConvertibleNoteMember 2022-01-01 2022-06-30 0000899460 us-gaap:SeniorNotesMember srt:MinimumMember 2022-06-30 0000899460 mnkd:MidCapCreditFacilityMember srt:MinimumMember 2022-06-30 0000899460 mnkd:MannGroupConvertibleNoteMember srt:MinimumMember 2022-06-30 0000899460 us-gaap:SeniorNotesMember srt:MaximumMember 2022-06-30 0000899460 mnkd:MidCapCreditFacilityMember srt:MaximumMember 2022-06-30 0000899460 mnkd:MannGroupConvertibleNoteMember srt:MaximumMember 2022-06-30 0000899460 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2021-12-31 0000899460 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel3Member us-gaap:SeniorNotesMember 2021-12-31 0000899460 us-gaap:SeniorNotesMember 2021-12-31 0000899460 us-gaap:CarryingReportedAmountFairValueDisclosureMember mnkd:MidCapCreditFacilityMember 2021-12-31 0000899460 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel3Member mnkd:MidCapCreditFacilityMember 2021-12-31 0000899460 us-gaap:CarryingReportedAmountFairValueDisclosureMember mnkd:MannGroupConvertibleNoteMember 2021-12-31 0000899460 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel3Member mnkd:MannGroupConvertibleNoteMember 2021-12-31 0000899460 mnkd:MannGroupConvertibleNoteMember 2021-12-31 0000899460 us-gaap:CarryingReportedAmountFairValueDisclosureMember mnkd:MilestoneRightsLiabilityMember 2021-12-31 0000899460 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel3Member mnkd:MilestoneRightsLiabilityMember 2021-12-31 0000899460 mnkd:MilestoneRightsLiabilityMember 2021-12-31 0000899460 mnkd:MannGroupConvertibleNoteMember 2021-12-31 0000899460 us-gaap:SeniorNotesMember us-gaap:MeasurementInputPriceVolatilityMember 2021-12-31 0000899460 mnkd:MannGroupConvertibleNoteMember us-gaap:MeasurementInputPriceVolatilityMember 2021-12-31 0000899460 us-gaap:SeniorNotesMember 2021-01-01 2021-12-31 0000899460 mnkd:MidCapCreditFacilityMember 2021-01-01 2021-12-31 0000899460 mnkd:MannGroupConvertibleNoteMember 2021-01-01 2021-12-31 0000899460 us-gaap:SeniorNotesMember srt:MinimumMember 2021-12-31 0000899460 mnkd:MidCapCreditFacilityMember srt:MinimumMember 2021-12-31 0000899460 mnkd:MannGroupConvertibleNoteMember srt:MinimumMember 2021-12-31 0000899460 us-gaap:SeniorNotesMember srt:MaximumMember 2021-12-31 0000899460 mnkd:MidCapCreditFacilityMember srt:MaximumMember 2021-12-31 0000899460 mnkd:MannGroupConvertibleNoteMember srt:MaximumMember 2021-12-31 0000899460 2021-11-30 0000899460 us-gaap:FairValueInputsLevel3Member 2021-11-30 0000899460 mnkd:ContolledEquityOfferingSalesAgreementMember mnkd:CantorFitzgeraldMember us-gaap:CommonStockMember srt:MaximumMember 2018-02-01 2018-02-28 0000899460 mnkd:ContolledEquityOfferingSalesAgreementMember mnkd:CantorFitzgeraldMember 2018-02-01 2018-02-28 0000899460 mnkd:AtMarketIssuanceSalesAgreementMember 2022-01-01 2022-06-30 0000899460 mnkd:AtMarketIssuanceSalesAgreementMember mnkd:CantorFitzgeraldMember us-gaap:CommonStockMember 2021-01-01 2021-06-30 0000899460 mnkd:AtMarketIssuanceSalesAgreementMember mnkd:CantorFitzgeraldMember us-gaap:CommonStockMember srt:WeightedAverageMember 2021-06-30 0000899460 mnkd:SeniorConvertibleNotesMember 2022-01-01 2022-06-30 0000899460 mnkd:SeniorConvertibleNotesMember 2021-01-01 2021-06-30 0000899460 mnkd:MannGroupConvertibleNoteMember 2022-01-01 2022-06-30 0000899460 mnkd:MannGroupConvertibleNoteMember 2021-01-01 2021-06-30 0000899460 mnkd:CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember 2022-01-01 2022-06-30 0000899460 mnkd:CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember 2021-01-01 2021-06-30 0000899460 mnkd:RestrictedStockUnitsAndMarketRestrictedStockUnitsMember 2022-01-01 2022-06-30 0000899460 mnkd:RestrictedStockUnitsAndMarketRestrictedStockUnitsMember 2021-01-01 2021-06-30 0000899460 mnkd:EmployeeStockPurchasePlanMember 2022-01-01 2022-06-30 0000899460 mnkd:EmployeeStockPurchasePlanMember 2021-01-01 2021-06-30 0000899460 mnkd:WarrantsAssociatedWithMidcapCreditFacilityMember 2021-01-01 2021-06-30 0000899460 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0000899460 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0000899460 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-06-30 0000899460 mnkd:EmployeeMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0000899460 mnkd:EmployeeMember us-gaap:RestrictedStockUnitsRSUMember 2022-04-01 2022-06-30 0000899460 mnkd:EmployeeMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-06-30 0000899460 mnkd:EmployeeMember mnkd:MarketRestrictedStockUnitsMember 2022-04-01 2022-06-30 0000899460 mnkd:EmployeeMember mnkd:MarketRestrictedStockUnitsMember 2022-01-01 2022-06-30 0000899460 mnkd:NonEmployeeDirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-04-01 2022-06-30 0000899460 mnkd:NonEmployeeDirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-06-30 0000899460 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0000899460 mnkd:EmployeeMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2022-01-01 2022-03-31 0000899460 mnkd:EmployeeMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2022-01-01 2022-03-31 0000899460 us-gaap:RestrictedStockUnitsRSUMember 2022-04-01 2022-06-30 0000899460 mnkd:EmployeeMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2022-04-01 2022-06-30 0000899460 mnkd:EmployeeMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2022-04-01 2022-06-30 0000899460 mnkd:EmployeeMember mnkd:MarketRestrictedStockUnitsMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2022-04-01 2022-06-30 0000899460 mnkd:EmployeeMember mnkd:MarketRestrictedStockUnitsMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2022-04-01 2022-06-30 0000899460 mnkd:EmployeeMember mnkd:MarketRestrictedStockUnitsMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2022-04-01 2022-06-30 0000899460 mnkd:EmployeeMember mnkd:MarketRestrictedStockUnitsMember mnkd:ShareBasedCompensationAwardsTrancheFourMember 2022-04-01 2022-06-30 0000899460 mnkd:EmployeeMember mnkd:MarketRestrictedStockUnitsMember mnkd:ShareBasedCompensationAwardsTrancheFiveMember 2022-04-01 2022-06-30 0000899460 mnkd:EmployeeStockOptionsAndPerformanceBasedOptionsMember 2022-06-30 0000899460 mnkd:EmployeeStockOptionsAndPerformanceBasedOptionsMember 2022-01-01 2022-06-30 0000899460 us-gaap:RestrictedStockUnitsRSUMember 2022-06-30 0000899460 mnkd:MarketRestrictedStockUnitsMember 2022-06-30 0000899460 mnkd:MarketRestrictedStockUnitsMember 2022-01-01 2022-06-30 0000899460 mnkd:RestrictedStockUnitsAndOptionsMember 2022-04-01 2022-06-30 0000899460 mnkd:RestrictedStockUnitsAndOptionsMember 2021-04-01 2021-06-30 0000899460 mnkd:RestrictedStockUnitsAndOptionsMember 2022-01-01 2022-06-30 0000899460 mnkd:RestrictedStockUnitsAndOptionsMember 2021-01-01 2021-06-30 0000899460 mnkd:EmployeeStockPurchasePlanMember 2022-04-01 2022-06-30 0000899460 mnkd:EmployeeStockPurchasePlanMember 2021-04-01 2021-06-30 0000899460 mnkd:EmployeeStockPurchasePlanMember 2022-01-01 2022-06-30 0000899460 mnkd:EmployeeStockPurchasePlanMember 2021-01-01 2021-06-30 0000899460 mnkd:EmployeeMember 2022-01-01 2022-06-30 0000899460 mnkd:EmployeeMember us-gaap:EmployeeStockMember 2022-01-01 2022-06-30 0000899460 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0000899460 us-gaap:CommonStockMember 2021-01-01 2021-06-30 0000899460 us-gaap:EmployeeStockMember 2022-06-30 0000899460 mnkd:DeerfieldManagementCompanyLpMember mnkd:MilestoneRightsLiabilityMember mnkd:AccruedExpensesAndOtherCurrentLiabilitiesMember 2022-06-30 0000899460 mnkd:CasperLLCMember 2021-11-01 2021-11-30 0000899460 mnkd:CasperLLCMember 2021-11-30 0000899460 srt:MinimumMember mnkd:CasperLLCMember 2021-11-30 iso4217:EUR mnkd:Vehicle 0000899460 us-gaap:VehiclesMember mnkd:MasterLeaseAgreementWithEnterpriseMember 2022-01-01 2022-06-30 0000899460 us-gaap:VehiclesMember mnkd:MasterLeaseAgreementWithEnterpriseMember 2022-06-30 0000899460 mnkd:OfficeMember mnkd:RussellRanchRoadIILLCMember 2017-05-01 2017-05-31 0000899460 mnkd:OfficeMember mnkd:RussellRanchRoadIILLCMember 2022-04-01 2022-04-30 0000899460 us-gaap:BuildingMember mnkd:MarlboroughLeaseMember 2022-06-01 2022-06-30 0000899460 us-gaap:EquipmentMember mnkd:VGoMember 2022-06-01 2022-06-30 0000899460 mnkd:OfficeAndVehicleMember 2022-06-30 0000899460 mnkd:OfficeAndVehicleMember 2021-12-31

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 10-Q

 

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2022

Or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                  to                 .

Commission file number: 000-50865

 

MannKind Corporation

(Exact name of registrant as specified in its charter)

 

 

Delaware

13-3607736

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

 

 

1 Casper Street 

Danbury, Connecticut

06810

(Address of principal executive offices)

(Zip Code)

(818) 661-5000

(Registrant’s telephone number, including area code)

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.01 per share

 

MNKD

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes      No   

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

 

 

 

 

Non-accelerated filer

Smaller reporting company

 

 

 

 

 

 

 

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes      No  

As of July 29, 2022, there were 257,338,259 shares of the registrant’s common stock, $0.01 par value per share, outstanding.

 

 

 

 


 

MANNKIND CORPORATION

Form 10-Q

For the Quarterly Period Ended June 30, 2022

TABLE OF CONTENTS

 

 

Page

PART I: FINANCIAL INFORMATION

2

 

 

Item 1. Financial Statements (Unaudited)

2

Condensed Consolidated Balance Sheets: June 30, 2022 and December 31, 2021

2

Condensed Consolidated Statements of Operations: Three and six months ended June 30, 2022 and 2021

3

Condensed Consolidated Statements of Comprehensive Loss: Three and six months ended June 30, 2022 and 2021

4

Condensed Consolidated Statements of Stockholders’ Deficit: Three and six months ended June 30, 2022 and 2021

5

Condensed Consolidated Statements of Cash Flows: Six months ended June 30, 2022 and 2021

6

Notes to Condensed Consolidated Financial Statements

7

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

34

Item 3. Quantitative and Qualitative Disclosures About Market Risk

41

Item 4. Controls and Procedures

41

 

 

PART II: OTHER INFORMATION

42

 

 

Item 1. Legal Proceedings

42

Item 1A. Risk Factors

42

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

72

Item 3. Defaults Upon Senior Securities

72

Item 4. Mine Safety Disclosures

72

Item 5. Other Information

72

Item 6. Exhibits

73

 

 

SIGNATURES

75

 

 

 

1


 

PART 1: FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

MANNKIND CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share and per share data)

 

 

June 30, 2022

 

 

December 31, 2021

 

ASSETS

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

$

35,507

 

 

$

124,184

 

Short-term investments

 

118,649

 

 

 

79,932

 

Accounts receivable, net

 

15,030

 

 

 

4,739

 

Inventory

 

20,573

 

 

 

7,152

 

Prepaid expenses and other current assets

 

3,717

 

 

 

3,482

 

Total current assets

 

193,476

 

 

 

219,489

 

Property and equipment, net

 

37,918

 

 

 

36,612

 

Goodwill

 

2,900

 

 

 

 

Other intangible asset

 

1,400

 

 

 

 

Long-term investments

 

32,596

 

 

 

56,619

 

Other assets

 

17,507

 

 

 

8,441

 

Total assets

$

285,797

 

 

$

321,161

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Accounts payable

$

7,823

 

 

$

6,956

 

Accrued expenses and other current liabilities

 

33,184

 

 

 

27,419

 

Financing liability — current

 

9,470

 

 

 

6,977

 

Deferred revenue — current

 

1,667

 

 

 

827

 

Recognized loss on purchase commitments — current

 

7,420

 

 

 

6,170

 

Total current liabilities

 

59,564

 

 

 

48,349

 

Senior convertible notes

 

224,670

 

 

 

223,944

 

Midcap credit facility

 

39,047

 

 

 

38,833

 

Mann Group convertible note

 

8,829

 

 

 

18,425

 

Accrued interest — promissory notes

 

86

 

 

 

404

 

Financing liability — long term

 

94,447

 

 

 

93,525

 

Recognized loss on purchase commitments — long term

 

65,996

 

 

 

76,659

 

Operating lease liability

 

5,928

 

 

 

1,040

 

Deferred revenue  — long term

 

29,762

 

 

 

19,543

 

Milestone liabilities

 

4,524

 

 

 

4,838

 

Deposits from customer

 

 

 

 

4,950

 

Total liabilities

 

532,853

 

 

 

530,510

 

Commitments and contingencies (Note 15)

 

 

 

 

 

 

 

Stockholders' deficit:

 

 

 

 

 

 

 

Undesignated preferred stock, $0.01 par value — 10,000,000 shares authorized;

   no shares issued or outstanding as of June 30, 2022 and December 31, 2021

 

 

 

 

 

Common stock, $0.01 par value - 400,000,000 shares authorized,

   257,276,847 and 251,477,562 shares issued and outstanding

   at June 30, 2022 and December 31, 2021, respectively

 

2,573

 

 

 

2,515

 

Additional paid-in capital

 

2,936,667

 

 

 

2,918,205

 

Accumulated other comprehensive loss

 

(1,206

)

 

 

 

Accumulated deficit

 

(3,185,090

)

 

 

(3,130,069

)

Total stockholders' deficit

 

(247,056

)

 

 

(209,349

)

Total liabilities and stockholders' deficit

$

285,797

 

 

$

321,161

 

 

See notes to condensed consolidated financial statements.

2


MANNKIND CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except per share data)

 

 

Three Months Ended

June 30,

 

 

Six Months Ended

June 30,

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue — commercial product sales

$

12,722

 

 

$

9,976

 

 

$

22,548

 

 

$

18,075

 

Revenue — collaborations and services

 

5,868

 

 

 

13,304

 

 

 

8,034

 

 

 

22,641

 

Royalties

 

304

 

 

 

 

 

 

304

 

 

 

 

Total revenues

 

18,894

 

 

 

23,280

 

 

 

30,886

 

 

 

40,716

 

Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of goods sold

 

4,617

 

 

 

4,411

 

 

 

6,901

 

 

 

8,726

 

Cost of revenue — collaborations and services

 

8,298

 

 

 

5,515

 

 

 

17,012

 

 

 

8,810

 

Research and development

 

4,893

 

 

 

2,329

 

 

 

8,429

 

 

 

4,771

 

Selling, general and administrative

 

26,043

 

 

 

20,056

 

 

 

46,740

 

 

 

37,469

 

(Gain) loss on foreign currency translation

 

(4,503

)

 

 

903

 

 

 

(6,486

)

 

 

(2,935

)

Loss on purchase commitments

 

 

 

 

339

 

 

 

 

 

 

339

 

Total expenses

 

39,348

 

 

 

33,553

 

 

 

72,596

 

 

 

57,180

 

Loss from operations

 

(20,454

)

 

 

(10,273

)

 

 

(41,710

)

 

 

(16,464

)

Other (expense) income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income, net

 

516

 

 

 

25

 

 

 

893

 

 

 

28

 

Interest expense on financing liability

 

(2,443

)

 

 

 

 

 

(4,814

)

 

 

 

Interest expense on notes

 

(6,642

)

 

 

(3,180

)

 

 

(9,390

)

 

 

(9,632

)

Loss on extinguishment of debt, net

 

 

 

 

(22,130

)

 

 

 

 

 

(22,130

)

Other expense

 

 

 

 

35

 

 

 

 

 

 

(241

)

Total other expense

 

(8,569

)

 

 

(25,250

)

 

 

(13,311

)

 

 

(31,975

)

Loss before provision for income taxes

 

(29,023

)

 

 

(35,523

)

 

 

(55,021

)

 

 

(48,439

)

Provision for income taxes

 

 

 

 

 

 

 

 

 

 

 

Net loss

$

(29,023

)

 

$

(35,523

)

 

$

(55,021

)

 

$

(48,439

)

Net loss per share - basic and diluted

$

(0.11

)

 

$

(0.14

)

 

$

(0.22

)

 

$

(0.20

)

Shares used to compute net loss per share - basic and diluted

 

253,644

 

 

 

249,295

 

 

 

252,775

 

 

 

247,970

 

 

See notes to condensed consolidated financial statements.

 

3


 

MANNKIND CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Unaudited)

(In thousands)

 

 

Three Months Ended

June 30,

 

 

Six Months Ended

June 30,

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Net loss

$

(29,023

)

 

$

(35,523

)

 

$

(55,021

)

 

$

(48,439

)

Other comprehensive loss:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized loss on available-for-sale securities

 

(130

)

 

 

 

 

 

(1,206

)

 

 

 

Comprehensive loss

$

(29,153

)

 

$

(35,523

)

 

$

(56,227

)

 

$

(48,439

)

 

 

See notes to condensed consolidated financial statements.  


4


 

 

 

MANNKIND CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

(Unaudited)

(In thousands)

 

 

 

Common Stock

 

 

Additional

Paid-In

 

 

Accumulated

Other

 

 

Accumulated

 

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Comprehensive

Loss

 

 

Deficit

 

 

Total

 

BALANCE, JANUARY 1, 2021

 

 

242,118

 

 

$

2,421

 

 

$

2,866,303

 

 

$

 

 

$

(3,049,143

)

 

$

(180,419

)

Net issuance of common stock associated

   with stock options and restricted stock

   units

 

 

390

 

 

 

4

 

 

 

393

 

 

 

 

 

 

 

 

 

397

 

Issuance of common stock under Employee

   Stock Purchase Plan

 

 

293

 

 

 

3

 

 

 

387

 

 

 

 

 

 

 

 

 

390

 

Stock-based compensation expense

 

 

 

 

 

 

 

 

1,935

 

 

 

 

 

 

 

 

 

1,935

 

Issuance of common stock pursuant to

   conversion of the Mann Group

   convertible note

 

 

3,830

 

 

 

38

 

 

 

9,535

 

 

 

 

 

 

 

 

 

9,573

 

Issuance of common stock pursuant to

   conversion of the Mann Group

   convertible note interest

 

 

170

 

 

 

2

 

 

 

425

 

 

 

 

 

 

 

 

 

427

 

Issuance of common stock pursuant to

   conversion of the 2024 convertible notes

 

 

1,667

 

 

 

17

 

 

 

4,983

 

 

 

 

 

 

 

 

 

5,000

 

Issuance of common stock pursuant to

   payoff of the 2024 convertible note

   interest

 

 

27

 

 

 

 

 

 

143

 

 

 

 

 

 

 

 

 

143

 

Issuance of at-the-market placement

 

 

578

 

 

 

6

 

 

 

1,880

 

 

 

 

 

 

 

 

 

1,886

 

Issuance costs associated with at-the-

   market placement

 

 

 

 

 

 

 

 

(38

)

 

 

 

 

 

 

 

 

(38

)

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(12,916

)

 

 

(12,916

)

BALANCE, MARCH 31, 2021

 

 

249,073

 

 

$

2,491

 

 

$

2,885,946

 

 

$

 

 

$

(3,062,059

)

 

$

(173,622

)

Net issuance of common stock associated

   with stock options and restricted stock

   units

 

 

520

 

 

 

5

 

 

 

(550

)

 

 

 

 

 

 

 

 

(545

)

Stock-based compensation expense

 

 

 

 

 

 

 

 

3,926

 

 

 

 

 

 

 

 

 

3,926

 

Premium on Mann Group convertible note

 

 

 

 

 

 

 

 

22,107

 

 

 

 

 

 

 

 

 

22,107

 

Issuance of common stock from market

   price stock purchase

 

 

25

 

 

 

 

 

 

106

 

 

 

 

 

 

 

 

 

106

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(35,523

)

 

 

(35,523

)

BALANCE, JUNE 30, 2021

 

 

249,618

 

 

$

2,496

 

 

$

2,911,535

 

 

$

 

 

$

(3,097,582

)

 

$

(183,551

)

 

 

 

Common Stock

 

 

Additional

Paid-In

 

 

Accumulated

Other

 

 

Accumulated

 

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Comprehensive

Loss

 

 

Deficit

 

 

Total

 

BALANCE, JANUARY 1, 2022

 

 

251,478

 

 

$

2,515

 

 

$

2,918,205

 

 

$

 

 

$

(3,130,069

)

 

$

(209,349

)

Net issuance of common stock associated

   with stock options and restricted stock

   units

 

 

450

 

 

 

4

 

 

 

125

 

 

 

 

 

 

 

 

 

129

 

Issuance of common stock under Employee

   Stock Purchase Plan

 

 

233

 

 

 

2

 

 

 

738

 

 

 

 

 

 

 

 

 

740

 

Stock-based compensation expense

 

 

 

 

 

 

 

 

2,806

 

 

 

 

 

 

 

 

 

2,806

 

Issuance of common stock from market

   price stock purchase plan

 

 

252

 

 

 

3

 

 

 

681